1.
A A Pract
; 11(12): 329-331, 2018 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29985837
RESUMO
Concerns remain regarding the use of direct thrombin inhibitors for cardiopulmonary bypass anticoagulation in pediatric patients with heparin-induced thrombocytopenia undergoing complex cardiac surgery. We describe the safe and effective use of epoprostenol sodium as an alternative therapy before heparin exposure for a pediatric patient with subacute heparin-induced thrombocytopenia and a ventricular assist device undergoing heart transplant.